PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy.\', \'Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.\', \'DNA Enzymology & Molecular Virology Unit, Institute of Molecular Genetics, National Research Council, Pavia, Italy.\', \'National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.\', \'Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.\', \'Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.\', \'Molecular Hematology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.\', \'Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy.\', \'School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan, Italy.\', \'Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan, Italy. scarlatti.gabriella@hsr.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-22958-8
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33976165
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all